Spironolactone: Side Effects and Clinical Implications

The presentation discusses the therapeutic use of spironolactone, particularly in treating acne, its side effects, and clinical implications. Speakers note an increase in the utilization of spironolactone over the past few years due to its benefits for patients, such as improving acne vulgaris and reducing sebum production. The primary side effect is menstrual irregularities, prominently mentioned across several studies, with data indicating that this affects a significant percentage of women taking the medication. Other side effects include breast tenderness, fatigue, and dizziness, and higher doses often lead to increased side effects. The discussion highlights that women on oral contraceptives generally experience fewer menstrual side effects, suggesting that those women may tolerate higher doses better. While monitoring potassium levels is not routinely necessary for younger women, it is recommended for those over 45 or with certain health conditions. The speaker noted that there is no substantial evidence linking spironolactone to increased breast cancer risk or venous thromboembolism. Concluding remarks emphasize the importance of considering individual patient factors when prescribing spironolactone and the need for ongoing monitoring in patients, especially regarding changes in menstrual cycles and potential side effects.